Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols
The ranges you will see in this guide come from two sources: preclinical research, which is mostly rodent and cell-culture work, and clinical-practice observation, meaning what providers and patients consistently report
For long-term weight management Semaglutide is generally a better option
Sale Price $9.99 ADD TO CART Larger Size - BD Insulin Syringes with PrecisionGlide needles Intramuscular (in the muscle) 25 gauge 1 inch needle 10 sterile needles / latex-free 3ml syringes come in one box Scale Alignment: It's easy to hold a BD syringe with the flanges or wings side to side with the scale markings facing you
Early postnatal proteolipid promoter-expressing progenitors produce multilineage cells in vivo
Entry price $35.88
